Bala, Rebecca D.
HRN: 20-22-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2023
01/17/2023
IV
4.5g
Q8
Sepsis CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes